Top Markets
Coin of the day
Recro Pharma, Inc. Recro Pharma, Inc.

Recro Pharma, Inc.

REPH
Rang in Aktien #25700
Recro Pharma, Inc. operates as a contract development and manufacturing... Recro Pharma, Inc. operates as a contract development and manufacturing organization (CDMO), offering comprehensive services for the development, production, and packaging of diverse therapeutic dosage forms. The company primarily specializes in small molecule therapeutic development, serving both domestic U.S. and international clients. Its extensive capabilities encompass a wide array of formats, including oral solid doses, sterile injectable solutions, oral liquid preparations, tablets, topical formulations, liquid/powder-filled capsules, ophthalmic droppers, liposomal products, and nano/microparticles. Furthermore, Recro Pharma provides specialized services such as aseptic fill/finish, lyophilization (freeze-drying), final packaging, and logistics management. Originally founded as Recro Pharma I, Inc., the company underwent a name change to Recro Pharma, Inc. in August 2008. The organization was established in 2007 and is headquartered in Exton, Pennsylvania.
Aktienkurs
$2.09
Zuletzt synchronisiert: 2022-03-21
Marktkapitalisierung
$47.04M
Veränderung (1 Tag)
-0.48%
Veränderung (1 Jahr)
0.00%
Land
US
Handel Recro Pharma, Inc. (REPH)

Kategorie

Aktien-Split-Historie für Recro Pharma, Inc. (REPH)
Die Aktie Recro Pharma, Inc. (Symbol: REPH) durchlief insgesamt 0 Aktiensplits.
Der letzte Aktiensplit fand am Aug 21, 2026 statt.
Eine REPH-Aktie, die vor dem Aug 21, 2026 gekauft wurde, entspricht heute 0 REPH-Aktien.
Liste der Aktiensplits
Jahr Aktien-Split Multiplikator Kumulierter Multiplikator
Nicht genügend Daten für die angegebenen Daten.
Aktiensplits ähnlicher Unternehmen oder Wettbewerber